Engineered liver tissue expands after transplant

July 19, 2017, Massachusetts Institute of Technology
Researchers created small “SEEDs” of liver tissue (right) composed of aggregates of liver cells and connective tissue (shown under a fluorescence microscope in left and center images). Credit: Stevens et al., Science Translational Medicine (2017)

Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

To help address that shortage, researchers at MIT, Rockefeller University, and Boston University have developed a new way to engineer , by organizing tiny subunits that contain three types of embedded into a biodegradable tissue scaffold. In a study of mice with damaged livers, the researchers found that after being implanted in the abdomen, the tiny structures expanded 50-fold and were able to perform normal liver tissue functions.

"There are just not enough organs to go around. Our goal is that one day we could use this technology to increase the number of transplants that are done for patients, which right now is very limited," says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science and a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science.

These engineered livers could also help the millions of people who suffer from but don't qualify for a , says Bhatia, the senior author of the study, which appears in the July 19 issue of Science Translational Medicine.

"These patients never really are transplant candidates, but they suffer from liver disease, and they live with it their whole lives. In that population you could imagine augmenting their liver function with a small engineered liver, which is an idea we're pretty excited about," she says.

Researchers mixed together human liver cells (hepatocytes) and human connective tissue cells (fibroblasts) to create small aggregates that grew and expanded. Credit: Stevens et al., Science Translational Medicine (2017)

The paper's lead author is Kelly Stevens, a former Koch Institute postdoc.

Liver regeneration

The new implantable liver builds on previous work by Bhatia's lab. In 2011, she developed an engineered tissue scaffold, about the size and shape of a contact lens, that could be implanted into the abdomen of a mouse. There, the liver cells would integrate with the mouse's circulatory system, allowing it to receive a blood supply and begin performing normal liver functions.

However, those implants contained fewer than 1 million hepatocytes (the cells that perform most of the liver's critical functions). A healthy human liver has about 100 billion hepatocytes, and Bhatia believes that at least 10 to 30 percent of that number would be necessary to help most patients.

To boost their hepatocyte population, the researchers decided to take advantage of a key trait of liver cells, which is that they can multiply to generate new liver tissue. "The liver is one of the only organs that can regenerate, and it's the mature cells that divide, without an intermediate stem cell. That's extraordinary," Bhatia says.

Small “SEEDs” of liver tissue that were grafted into mice grew and began producing functional markers (shown in red and green) under the influence of regenerative cues. Credit: Stevens et al., Science Translational Medicine (2017)

Working with Christopher Chen, a professor of biomedical engineering at Boston University, Bhatia's team designed microfabricated structures that incorporate spherical "organoids" made of hepatocytes and fibroblasts, as well as cords of endothelial cells, which are the building blocks of blood vessels. These two types of structures are organized into patterns and embedded into fibrin, a tough protein normally involved in blood clotting.

Once the constructs are implanted into a mouse, they receive regenerative signals from the surrounding environment. These signals, which include growth factors, enzymes, and molecules, are naturally produced when liver damage occurs. These signals stimulate the endothelial cells to form blood vessels and to release factors that stimulate hepatocyte proliferation, resulting in 50-fold expansion of the original tissue.

"The idea is that it's the seed of an organ, and you organize it in a way that it can be responsive to these regenerative signals, but it's a minimal unit of what you eventually want to end up with," Bhatia says. "What's really exciting about this is that the architecture of the tissue that emerges looks a lot like the liver architecture in the body."

In this case, the researchers worked with Charles Rice, a virology professor at Rockefeller University, to implant the tissue into mice with a genetic liver disorder called tyrosinemia. When treated with a repair-inducing drug, the livers of these mice begin produce regenerative signals, and the researchers expect that patients receiving the transplants would produce similar signals. They are also looking into the possibility of embedding the implant with additional regeneration-promoting chemicals that they discovered in 2013.

Researchers 3D printed lattices of carbohydrate glass (shown in left and center images), which they filled with living cells (shown in right). Credit: Stevens et al., Science Translational Medicine (2017)
Fully functional

The liver performs hundreds of functions for the body, most of which are related to regulation of metabolism, detoxification of harmful substances, and bile production. Tests of the implanted human livers showed that examples of all of these functions were occurring normally in the host mice.

Intriguingly, the researchers also found that after implantation, the tissue began forming tiny precursors to bile ducts, which they had not designed. "The next step for us is to find out how they got there, whether we can make it happen faster and in a more organized way, and whether they're functional," Bhatia says.

The researchers are also exploring the best source of cells for these implants. Currently they are using liver cells from human organs that can't be transplanted because they were on ice for too long after being removed from the donor or had some unusual anatomy. Other possibilities include using taken from the patient who will be receiving the , which would avoid the need for immunosuppressive drugs, or using cells generated from induced pluripotent stem cells.

Explore further: New progress toward finding best cells for liver therapy

More information: K.R. Stevens el al., "In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease," Science Translational Medicine (2017). stm.sciencemag.org/lookup/doi/ … scitranslmed.aah5505

Related Stories

New progress toward finding best cells for liver therapy

April 26, 2017
In a new study, researchers demonstrate successful transplantation of fetal rat liver cells to an injured adult rat liver. The work is an important step toward using transplanted cells to treat liver failure, which currently ...

Artificial bile ducts grown in lab, transplanted into mice could help treat liver disease

July 3, 2017
Cambridge scientists have developed a new method for growing and transplanting artificial bile ducts that could in future be used to help treat liver disease in children, reducing the need for liver transplantation.

Functional human tissue-engineered liver generated from stem and progenitor cells

August 30, 2016
A research team led by investigators at The Saban Research Institute of Children's Hospital Los Angeles has generated functional human and mouse tissue-engineered liver from adult stem and progenitor cells. Tissue-engineered ...

Researchers are one step closer to artificial livers

June 2, 2013
Prometheus, the mythological figure who stole fire from the gods, was punished for this theft by being bound to a rock. Each day, an eagle swept down and fed on his liver, which then grew back to be eaten again the next day.

Newly discovered cells regenerate liver tissue without forming tumors

August 13, 2015
The mechanisms that allow the liver to repair and regenerate itself have long been a matter of debate. Now researchers at University of California, San Diego School of Medicine have discovered a population of liver cells ...

Scientists shed light on how liver repairs itself

March 4, 2012
Scientists have shed light on how the liver repairs itself with research that could help develop drugs to treat liver disease.

Recommended for you

Exercise-induced hormone irisin triggers bone remodeling in mice

December 13, 2018
Exercise has been touted to build bone mass, but exactly how it actually accomplishes this is a matter of debate. Now, researchers show that an exercise-induced hormone activates cells that are critical for bone remodeling ...

Law professor suggests a way to validate and integrate deep learning medical systems

December 13, 2018
University of Michigan professor W. Nicholson Price, who also has affiliations with Harvard Law School and the University of Copenhagen Faculty of Law, suggests in a Focus piece published in Science Translational Medicine, ...

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Pain: Perception and motor impulses arise in brain independently of one another

December 13, 2018
Pain is a negative sensation that we want to get rid of as soon as possible. In order to protect our bodies, we react by withdrawing the hand from heat, for example. This action is usually understood as the consequence of ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Researchers give new insight to muscular dystrophy patients

December 13, 2018
New research by University of Minnesota scientists has revealed the three-dimensional structure of the DUX4 protein, which is responsible for the disease, facioscapulohumeral muscular dystrophy (FSHD). Unlike the majority ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.